connexintx.co.uk valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Crawl-delay:
Meta Tags
Title Connexin Therapeutics | Preserving Vision Preventing
Description Home About Us Science Leadership Pipeline Partners Contact --> Preserving Vision Preventing Blindness ABOUT US Glaucoma, diabetic retinopathy, and othe
Keywords N/A
Server Information
WebSite connexintx faviconconnexintx.co.uk
Host IP 205.134.255.219
Location United States
Related Websites
Site Rank
More to Explore
connexintx.co.uk Valuation
US$1,194
Last updated: 2023-05-19 19:29:52

connexintx.co.uk has Semrush global rank of 0. connexintx.co.uk has an estimated worth of US$ 1,194, based on its estimated Ads revenue. connexintx.co.uk receives approximately 137 unique visitors each day. Its web server is located in United States, with IP address 205.134.255.219. According to SiteAdvisor, connexintx.co.uk is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,194
Daily Ads Revenue US$1
Monthly Ads Revenue US$33
Yearly Ads Revenue US$396
Daily Unique Visitors 9
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
connexintx.co.uk. A 14400 IP: 205.134.255.219
connexintx.co.uk. NS 3600 NS Record: dns1.p08.nsone.net.
connexintx.co.uk. NS 3600 NS Record: dns2.p08.nsone.net.
connexintx.co.uk. NS 3600 NS Record: dns3.p08.nsone.net.
connexintx.co.uk. NS 3600 NS Record: dns4.p08.nsone.net.
connexintx.co.uk. NS 3600 NS Record: ns01.squarespacedns.com.
connexintx.co.uk. NS 3600 NS Record: ns02.squarespacedns.com.
connexintx.co.uk. NS 3600 NS Record: ns03.squarespacedns.com.
connexintx.co.uk. NS 3600 NS Record: ns04.squarespacedns.com.
connexintx.co.uk. MX 14400 MX Record: 5 alt2.aspmx.l.google.com.
connexintx.co.uk. MX 14400 MX Record: 1 aspmx.l.google.com.
connexintx.co.uk. MX 14400 MX Record: 5 alt1.aspmx.l.google.com.
connexintx.co.uk. MX 14400 MX Record: 10 alt4.aspmx.l.google.com.
connexintx.co.uk. MX 14400 MX Record: 10 alt3.aspmx.l.google.com.
HtmlToTextCheckTime:2023-05-19 19:29:52
Home About Us Science Leadership Pipeline Partners Contact --> Preserving Vision Preventing Blindness ABOUT US Glaucoma, diabetic retinopathy, and other serious eye diseases associated with aging are a major risk factor for the vision loss and blindness. By exploiting our understanding of the mechanisms of cell death during these diseases, we can contribute to the need to reduce healthcare costs and reduce the burden that blindness can place on our society. Preserving Vision…Preventing Blindness Connexin Therapeutics Ltd. is a UK based biotech company with R&D and Management in the UK and a US office in New York. We are driven by a simple, but powerful goal: to protect vision in patients with progressive glaucoma and other serious eye diseases which cause blindness. Current estimates suggest a global glaucoma prevalence of over 60 million cases. And, with an aging population, this prevalence is growing rapidly. Most cases are associated with elevated intraocular pressure. However,
HTTP Headers
HTTP/1.1 200 OK
Date: Sun, 13 Nov 2022 08:41:31 GMT
Server: Apache
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Content-Type: text/html; charset=UTF-8

Copyright © 2022 WebZZ.US 0.0216